PENANG, 27 January 2016 – The Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM) in collaboration with Siemens Healthcare Sdn Bhd will be organising a Symposium on Recist and Beyond, which will be held on 24 February 2016 (Wednesday) at the Animal Research Centre Seminar Room of AMDI, Universiti Sains Malaysia Bertam, Kepala Batas, Penang.

This Symposium is on the Response Evaluation Criteria in Solid Tumours (RECIST) criteria [a set of published rules that define when tumour conditions in cancer patients improve (respond), remain the same (stabilise), or worsen (progress) during treatment] which were published in February 2000, from an international collaboration which includes the European Organisation for Research and Treatment of Cancer, National Cancer Institute of the United States, and the National Cancer Institute of Canada Clinical Trials Group.

Key features of the original RECIST, version 1.0, included definitions of the minimum size of measurable lesions, instructions on how many lesions to follow, and the use of uni-dimensional measures in the evaluation of overall tumour burden.

RECIST has subsequently been widely accepted as a standardised measure of tumour response, particularly in oncologic clinical trials in which the primary end points are objective response or time to progression.

In January 2009, a revised RECIST guideline (version 1.1) based on a database consisting of more than 6,500 patients with greater than 18,000 target lesions was presented by the RECIST Working Group.

Awareness and knowledge of the new criteria are essential for those involved in the imaging and response assessment of cancer patients.

The tentative programme consists of:

* Introduction - Prof. Ibrahim Lutfi Bin Shuaib,                                                                                            

* Report of Imaging of Tumour Staging, Oncologist’s Expectation - Dr. Gokula Kumar a/l Appalanaido,                                                                                                                                             

* Radiologist Practice - Dr. Noor Khairiah Binti A. Karim,                                                                          

* RECIST - Dr. Marco Das,                                                                                                                                    

* Beyond RECIST - Dr. Marco Das,                                                                                                             

* Emerging CT Techniques in Oncology CT Perfusion - Dr. Marco Das, and                                           

* Emerging CT Techniques in Oncology CT Dual Energy - Dr. Marco Das.

For further information concerning the participation in this symposium, please contact:

Ms. Noor Faizura Binti Zainal                                                                                                                             

(O) +604 - 562 2651/2652,     (M) +6017 - 414 4776,           (E) This email address is being protected from spambots. You need JavaScript enabled to view it.,            (F) +604 - 562 2804.

 

Text: Hafiz Meah Ghouse Meah